首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 46 毫秒
1.
目的:观察黄芪注射液对急性心肌梗死(AMI)早期患者左室重塑和心功能的影响。方法:108例AMI患者随机分为黄芪治疗组(治疗组,54例)和常规治疗组(对照组,54例),于治疗1周及4周后行超声心动图检查,测定左室舒张末容积指数(LVEDVI)、左室收缩末容积指数(LVESVI)、左室前部内膜弧长(ASL)和左室后部内膜弧长(PSL),治疗4周后同时行核素心血池心室造影,判断左室收缩与舒张功能;另外,治疗前后测定血浆丙二醛(MDA)、血管内皮细胞数(CEC)及红细胞膜超氧化物歧化酶(SOD)水平。结果:治疗4周后,治疗组LVEDVI、LVESVI和ASL无明显变化,而对照组则明显提高,两组比较差异有显著性(P<0.05);治疗组左室射血分数(LVEF)、左室峰射血率(PER)及左室峰充盈率(PFR)较对照组明显提高,左室峰充盈率时间(TPFR)较对照组缩短,差异均有显著性(P<0.05);同时,MDA、CEC显著降低,而SOD明显升高,与治疗前及对照组比较,差异均有显著性(P<0.05或P<0.01)。结论:黄芪注射液为预防及逆转AMI左室重塑、改善心脏功能的有效药物之一。  相似文献   

2.
目的;探讨镇心痛对冠心病心绞痛患者心功能及血液流变学的影响,方法:将64例冠心病心绞痛患者应用镇心痛口服液治疗30天,用电脑超声观察治疗前后心功能射血分数(EF),心脏每分钟射血量(CO),心脏指数(CI),左室舒张末期容积(EDV),左室收缩末期容积(ESV),血液流变学观察全血比低,高切粘度及血浆比粘度,红细胞压积及纤维蛋白原,结果:治疗后国治疗前EF有显著升高(P〈0.01),CO,CI升高  相似文献   

3.
目的:研究中药汤剂防己黄芪汤加减对气虚血瘀型慢性心衰的治疗效果。方法:选取我院住院病人共计320例,采用信封随机法分为两组,用药前后测定左心室舒张末容积(LVEDV)、左室收缩末期容积(LVESV)、右室射血分数(EF)、小轴短缩率(Fs)等指标。结果:两组病人治疗前后左室舒缩功能改善有统计学差异(*P〈O.01);对于收缩功能的改善治疗组优于对照组(*P〈O.01);对于舒张功能的改善无显著差异(*P〉o.05)。结论:联合加减防己黄芪汤对于改善气虚血瘀型慢性心衰病人左室收缩功能较单纯西药组效果更佳。  相似文献   

4.
目的:探讨卡托普利联合美托洛尔治疗慢性心力衰竭的疗效。方法:回顾性分析我院140例慢性心力衰竭患者,随机分2组,比较2组患者疗效差异。结果:治疗组70例患者,经过常规治疗基础上的卡托普利联合美托洛尔治疗,总有效率为92.86%;对照组70例,经过常规治疗,总有效率为64.29%;两组疗效经统计学分析,P〈0.05,有显著性差异。两组患者治疗前的左室收缩末期容积(LVESV),左室舒张末期容积(LVEDV)左室射血分数(LVEF)值比较,无显著性差异,P〉0.05;治疗后的各项指标比较,差异有显著性,P〈0.05。结论:联合应用ACEI类药物及β-受体阻滞剂是非常必要的,这样可以极大限度地提高生存质量,降低因病情加重而带来的痛苦和沉重的医疗费用。  相似文献   

5.
目的:观察麝香保心丸抗心肌梗塞后左室重构的效应。方法:将90例急性心肌梗塞(AMI)病人随机分为麝香保心丸治疗组(治疗组45例)和常规治疗组(对照组45例),于治疗后1周及3个月后分别行超声心动图检查,测定左室舒张末期内径(LVD),左室舒张末期容积(LVEDV),左室收缩末期容积(LVESV),局部室壁运动记分和左室射血分数(LVEF)。结果:治疗3个月后,治疗组LVD、LVEDV、LVESV、局部室壁运动记分无明显变化,而对照组则明显增加,两组比较差异有显著性(P〈0.05);治疗组LVEF增加,而对照组则下降,差异具有显著性意义(P〈0.05)。结论:麝香保心丸可抑制AMI后舒张末内径的扩大,改善心室局部运动障碍和整体左室功能,具有一定的抗心室重构作用。  相似文献   

6.
目的应用实时三维超声心动图(RT3DE)评价延迟经皮冠状动脉介入治疗(PCI)对急性心肌梗死(AMI)患者左心室功能的影响。方法选择首次AMI住院患者56例,根据是否行延迟PCI治疗,将患者分为PCI治疗组(30例)和药物治疗组(26例)。所有患者于治疗前和治疗后3个月、6个月分别进行RT3DE检查,对采集的三维超声图像进行脱机处理,得出左室舒张末期容积(LVEDV)、左室收缩末期容积(LVESV)及左心室射血分数(LVEF),比较两组患者左心功能的差异。结果PCI治疗组治疗后3个月、6个月较术前LVEDV、LVESV降低(P〈0.05),LVEF提高(P〈0.05)。药物治疗组治疗3个月、6个月时,各指标差异均无统计学意义。治疗后3个月及6个月时PCI治疗组与药物治疗组比较,LVEDV、LVESV、LVEF均有统计学意义(P〈0.05)。结论延迟PCI能明显改善AMI后左室重构,提高左心功能,改善患者预后。RT3DE可准确、方便的评价AMI患者左室整体心功能。  相似文献   

7.
郭治平  郭智  叶椿香 《中医药研究》2009,(11):1286-1287
目的观察急性心肌梗死(AMI)冠脉介入(PCI)术后患者应用心脑舒通胶囊治疗后血浆脑钠肽水平及心脏超声改变。方法62例冠心痛AMI患者,施行PCI术治疗后。随机分为心脑舒通组和对照组。心脑舒通组在AMI常规西医治疗的基础上,加服心脑舒通胶囊。于治疗前、治疗后1个月、治疗后6个月分别检测患者血浆脑钠肽水平,并行超声心动图检查,测量左室舒张末期内径、左室收缩末期内径、左室射血分数。结果心脑舒通组与对照组治疗后脑钠肽水平均呈下降趋势,心脑舒通组治疗1个月、6个月与同时间段对照组相比血浆脑钠肽水平下降。治疗1个月两组左室舒张末期内径、左室收缩末期内径、左室射血分数均无统计学意义(P〉0.05),治疗6个月心脑舒通组左室舒张末期内径、左室收缩末期内径较对照组明显缩小(P〈0.01),左室射血分数较对照组明显升高(P〈0.01)。结论急性心肌梗死冠状动脉介入术后患者在AMI常规西医治疗的基础上,加用心脑舒通胶囊可改善心功能、抑制左心室重构。  相似文献   

8.
目的探讨糖尿病合并慢性心力衰竭(心衰)患者糖化血红蛋白(HbA1c)水平与NYHA心功能分级心功能指标的关系。方法选择133例资料完整的糖尿病合并慢性心衰患者,临床评价NYHA心功能分级。彩色多普勒超声心动图检测左室舒张末期容积(LVEDV),计算左室舒张末期容积指数(LVEDVI)、左室射血分数(LVEF),运用相关性分析与逐步回归法分析心功能与HbA1c的相关性。结果不同NYHA心功能分级糖尿病合并慢性心衰患者之间的HbA1c水平具有显著性差异(P〈0.01)。心功能Ⅳ级的患者HbA1c水平明显高于心功能Ⅱ、Ⅲ级的患者(P〈0.01)。LVEDVI与HbA1c水平呈正相关(r=0.34,P=0.001);LVEF与HbA1c水平呈负相关(r=-0.39,P=0.009)。结论糖尿病合并慢性心力衰竭患者的心功能与HbA1c有相关性。  相似文献   

9.
目的观察黄芪对慢性心力衰竭(CHF)患者左室重构的影响。方法 85例CHF患者随机分为对照组和治疗组。对照组采用常规治疗,治疗组在对照组治疗方法的基础上联用黄芪注射液40 mL,静脉输注,每日1次,治疗8周。结果治疗组室间隔厚度(IVST)、左室后壁厚度(LVPWT)、左室舒张末期内径(LVDd)、左室质量指数(LVMI)均明显下降,左室射血分数(LVEF)明显提高(P〈0.05或P〈0.01),且部分指标疗效优于对照组(P〈0.05)。结论黄芪注射液能够逆转CHF患者左室重构,并能改善左室收缩功能。  相似文献   

10.
目的探讨实时三平面超声心动图(RT-3PE)与二维超声心动图(2DE)双平面Simpson’s法测量心肌梗死患者左室容积和左心室射血分数(LVEF)的相关性。方法应用RT-3PE和二维超声心动图(2DE)双平面Simpson’s法同期测量30例心肌梗死患者的左室舒张末期容积(LVEDV)、左室收缩末期容积(LVESV)和LVEF,并将两种方法的测值进行相关性分析。结果 RT-3PE法和2DE双平面法所测的LVEDV、LVESV和LVEF之间均无统计学意义(P〉0.05),且相关性良好(r分别为0.89、0.96和0.86,P〈0.01)。结论实时三平面超声心动图可以实时在线测定心肌梗死患者左心室容积和左室射血分数,为临床上定量分析心肌梗死患者左心室容积和左室射血分数提供了一种检查快速、简便和无创的新方法。  相似文献   

11.
目的 通过电感耦合等离子体质谱(inductively coupled plasma mass spectrometry,ICP-MS)法建立加味左金丸中Cd、Pb、As、Hg、Co、V、Ni、Cu、Li、Sb、Ba、Mo、Sn、Cr、Na、Mg、Al、Ca、Ti、Mn、Fe、Zn、Ga、Se、Sr、Tl共计26种无机元素的测定方法。方法 加味左金丸通过微波消解法处理后,根据相对分子质量的大小选择内标物,其中7Li、23Na、24Mg、27Al、40Ca、48Ti、51V、52Cr、55Mn、56Fe、58Ni、59Co、63Cu、66Zn、70Ga、75As、77Se、86Sr以72Ge作为内标;95Mo、114Cd、118Sn、121Sb、137Ba以115In作为内标;202Hg、205Tl、208Pb以209Bi作为内标。对标准品溶液、空白溶液与供试品溶液进行分析,采用标准曲线法进行定量分析。通过ICP-MS法进行测定。结果 26种无机元素线性的相关系数r ≥ 0.999 6,检出限为0.001~1.500μg/L,定量限为0.01~5.00 μg/L,精密度与重复性试验的RSD均小于5%,平均回收率在82.64%~106.44%,RSD均小于5%。对3个厂家的12批样品进行了测定,26种元素的含量差异较大,其中Na、Mg、Ca、Fe 4种元素的含量比较高,均大于500 μg/g,Cd、Pb、As、Hg、Co、Li、Sb、Mo、Sn、Cr、Se、Tl的含量比较低,均小于1 μg/g。由结果可知,人体的常量元素,如Na、Mg、Ca的含量比较高,Cd、Pb、As、Hg等有害元素含量比较低。根据《中国药典》2020年版一部的要求,本品中Cd、Pb、As、Hg与Cu均符合规定。结论 该方法快速、准确,可以用于加味左金丸中无机元素的测定。  相似文献   

12.
A girl, three and a half years old at the respective date, premature in 25th week of gestation, had been presented. On day three after birth, she had had a IVH III° right and left with severe involvement of parenchyma and other multiple complications, e. a. infant respiratory distress syndrome up to the 42nd day postpartum, and epileptic attacks with apnoeic events.  相似文献   

13.
目的::研究七味红花殊胜敬对缺血再灌注肝损伤的保护作用.方法:在大鼠肝缺血再灌注模型上,观察七味红花殊胜散对缺血再灌注肝损伤引起的血清丙二醛(MDA)、超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-Px)、一氧化氮(NO)含量的变化.结果:七味红花殊胜散对大鼠血清MDA、SOD、GSH与再灌组比较有明显差异(P<0.05),NO含量与再灌组比较有明显差异(P<0.05).结论:七味红花殊胜散对大鼠急性缺血再灌注肝损伤具有保护作用.  相似文献   

14.
BackgroundYamamoto New Scalp Acupuncture (YNSA) is a well-known acupuncture system for human patients which was developed by Dr. Yamamoto.ObjectiveMy aim was to transpose the human YNSA map onto canines and felines.MethodI started researching a canine/feline YNSA map in 2002. I investigated approximately 3,000 canines and felines for YNSA and 2,500 for Tail Acupuncture. The ratio of canines and felines was 6 to 4. I researched and found all the equivalent points by palpating animal patients on the basis of an exact Neck Diagnosis.ResultsI nearly completed the map in 2006. The points in the occipital region are incomplete and my research is still in progress. In the process of researching canine/feline YNSA points, I accidentally found the other microsystems around the tail and named it “Tail Acupuncture”.ConclusionsYNSA and Tail Acupuncture are acupuncture systems utilizing microsystems and support each other in canines and felines. The merits of YNSA and Tail Acupuncture are 1) immediate effects, such as in cases of lameness, 2) simplicity in finding the exact points to treat and 3) the scalp and the tail can be utilized separately or together as treatment zones, according to the situation.  相似文献   

15.
16.
17.
The locomotor system is one of the major fields of application for acupuncture. The results of the large acupuncture studies funded by German Health Insurances from 2000 until 2006 are impressive and repressive: they restrict acupuncture application by allocation of reimbursement and create the necessity of reorientation, since acupuncture can neither be adequately described nor prescribed solely on the basis of disease entities. Regarding these disease entities, it seems rather necessary to analyse the layers of problems and formulate a hierarchy of therapeutic goals instead. Only in this way the effects of acupuncture, related techniques and further therapeutic modalities can be matched with the set of objectives. The article presents general principles and follows their application from biological aspects to implications for the locomotor system and consequences for the application of physical therapy. The manual of acupuncture focuses on therapeutic effects and objectives first, and then goes on to sketch simple therapeutic strategies and finally complex approaches within acupuncture. These may encompass acupuncture, microsystem acupuncture and complex therapeutic modes.  相似文献   

18.

Background

Since the onset of her menopause about ten years ago, a sixty-year old patient has been suffering from hot flashes and sleep disorders causing her to become increasingly anxious and nervous. As the patient's mother had died of breast cancer, substitution of hormones was not advisable. Relaxation methods such as Yoga and Autogenic Training could only mildly alleviate the symptoms.

Objective

To effectively treat the sleep disorder, improve quality of life, lessen frequency and severity of hot flashes

Methods

Weekly sessions with ear- and body acupuncture for ten weeks

Results

After the third acupuncture session the patient reported a decrease of nightly waking episodes but suffered from acute pain in the neck as well as shoulder region. After nine therapy sessions, the patient reported a 50% decrease of nightly waking episodes. The hot flashes, however, remained unchanged.

Discussion

In this case, acupuncture significantly improved the patient's sleeping disorder. It also reduced the symptoms of anxiety and nervousness. Other menopausal symptoms such as hot flashes and dryness of mucous tissues, could not be influenced.  相似文献   

19.

Background

Acupuncture as a regulative therapy is well-suited for the treatment of functional, reversible disorders. Additionally, the WHO recommends its application for pain therapy in cases of arthritis and back pain due to various causes. This case study should clarify which paths to take in the case of a multi-morbid patient suffering from chronic pains due to polyarthrosis.

Objective

Pain reduction and improvement of quality of life as well as improvement of sleep quality.

Methods

Annual treatment series consisting of 10 sessions each, one session per week.

Results

short-term pain reduction before undergoing endoprosthetic surgery; considerable improvement of general status and sleep.

Conclusions

Acupuncture may bring temporal relief in cases of chronic pain due to osteoarthritis and should therefore be applied in combination with western medicine. Acupuncture is particularly well-suited to treat the co-emergent vegetative symptoms.  相似文献   

20.
目的揭示常见证候荷瘤小鼠神经-内分泌-免疫组织基因转录的总体特征。方法采用小鼠标准化四诊及辨证方法,及Gene Chip Mouse Exon1.0ST Array等技术,检测H22荷瘤小鼠早期邪毒壅盛(邪毒)和气虚、中期阳气虚、中晚期气阴阳虚等4个常见证候下丘脑、垂体、肾上腺、睾丸、脾脏、胸腺、肿瘤RNA的转录与剪接。结果正常昆明种雄性小鼠下丘脑、垂体、肾上腺RNA电泳的28S峰低于18S,而睾丸、脾脏、胸腺、肿瘤相反。肿瘤发生的早期,下丘脑、垂体、肾上腺基因表达模式发生显著改变,邪毒尤甚,出现了失代偿。下丘脑28SRNA迅速抬升并持续,气虚强于邪毒。垂体RNA总量降低,28S陡降,邪毒尤甚。肾上腺RNA电泳特征类似垂体,气虚与邪毒相近,中晚期气阴阳虚尤甚。睾丸变化不明显。随着病情发展,脾脏重量持续增加,而胸腺相反,重量持续下降,蛋白合成和糖代谢下降。肿瘤组织蛋白合成与糖代谢,邪毒大于气虚。以上7个组织与正常对照组相比,有9127个基因表达发生差异、51126个外显子剪接发生差异。结论神经-内分泌-免疫网络组织基因转录的差异是荷瘤小鼠不同证候内在重要的物质基础。  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号